Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Presbyopia - Overview
Presbyopia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Presbyopia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Presbyopia - Companies Involved in Therapeutics Development
Allergan Ltd
Cellix Bio Pvt Ltd
Eyenovia Inc
Kedalion Therapeutics Inc
Kubota Vision Inc
Novartis AG
Ocuphire Pharma Inc
Orasis Pharmaceuticals Ltd
Plex Pharmaceuticals Inc
Presbyopia Therapies LLC
Reven Pharmaceuticals Inc
ViewPoint Therapeutics Inc
Presbyopia - Drug Profiles
(aceclidine + tropicamide) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diclofec sodium + pilocarpine hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(oxymetazoline hydrochloride + pilocarpine hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(phentolamine mesylate + pilocarpine) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AGN-241622 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAP-1160 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CLXOPH-561 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EV-06 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KT-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
oxymetazoline hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pilocarpine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RPEC-1004A - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Presbyopia and Cataract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VP-1001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Presbyopia - Dormant Projects
Presbyopia - Product Development Milestones
Featured News & Press Releases
Oct 10, 2019: Orasis Pharmaceuticals announces CSF-1 Eye Drop successfully met primary endpoint in phase 2b clinical study in Presbyopia
Mar 27, 2019: Orasis Announces Initiation of Phase 2b Clinical Study of CSF-1 for the Treatment of Presbyopia
Nov 27, 2018: Orasis Announces Appointments of Richard L. Lindstrom, Eric D. Donnenfeld, and John Berdahl to its Scientific Advisory Board
Aug 02, 2018: Eye drop improves near vision in presbyopia patients
May 05, 2016: Encore Vision Announces Successful Phase I-II Study of Topical EV06 for the Treatment of Presbyopia
May 02, 2016: Encore Vision Announces Positive Results from the Phase I-II Study of Topical EV06 for the Treatment of Presbyopia
Jan 25, 2016: Encore Vision Announces Completion of Target Enrollment
Oct 05, 2015: Encore Vision Announces First Subject Enrolled in Study of Topical Treatment for Presbyopia
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Presbyopia, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Presbyopia, H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Presbyopia - Pipeline by Allergan Ltd, H1 2020
Presbyopia - Pipeline by Cellix Bio Pvt Ltd, H1 2020
Presbyopia - Pipeline by Eyenovia Inc, H1 2020
Presbyopia - Pipeline by Kedalion Therapeutics Inc, H1 2020
Presbyopia - Pipeline by Kubota Vision Inc, H1 2020
Presbyopia - Pipeline by Novartis AG, H1 2020
Presbyopia - Pipeline by Ocuphire Pharma Inc, H1 2020
Presbyopia - Pipeline by Orasis Pharmaceuticals Ltd, H1 2020
Presbyopia - Pipeline by Plex Pharmaceuticals Inc, H1 2020
Presbyopia - Pipeline by Presbyopia Therapies LLC, H1 2020
Presbyopia - Pipeline by Reven Pharmaceuticals Inc, H1 2020
Presbyopia - Pipeline by ViewPoint Therapeutics Inc, H1 2020
Presbyopia - Dormant Projects, H1 2020